Daily as of 3 Nov 16:00 ET
- Price
- between the two $23.17 vs 50 $23.54 / 200 $22.43
- Projection
- ๐Death cross estimated in 14 to 20 bars
- Test
- No active test
- Last cross
- ๐จGolden cross 14 Jul 2025 ยท projected 30 bars out
Tango Therapeutics (TNGX) is a NASDAQ-listed common stock that Cruxta has tracked for 50/200 crosses since 2022.
Right now the daily is the chart to watch. The 50 SMA has sat above the 200 since Jul 2025, but the two have been closing on each other and a death cross is projected within 20 bars. On both the daily and the 4-hour, price sits between the 50 and the 200; on the weekly it is above both.
| Crossed | Direction | Timeframe | Projected | Cross test |
|---|---|---|---|---|
| 1 Sep 2026 | ๐Death | 4-hour | 16 bars out | Not tested |
| week of 16 Feb 2026 | ๐จGolden moderate | weekly | 25 bars out | Not tested |
| 14 Jul 2025 | ๐จGolden steep | daily | 30 bars out | Not tested |
| 9 Jun 2025 | ๐จGolden | 4-hour | 25 bars out | โ |
| 9 Oct 2024 | ๐Death | daily | 19 bars out | Not tested |
Cruxta · 50/200 moving-average crosses on US equities. Recorded crosses are observations. Projected crosses are projections, not advice.